Visual abstract - Safety and efficacy of Lumasiran (RNAi) in adult and pediatric patients with Primary Hyperoxaluria Type 1
ISN Academy. Deschenes G. 06/06/19; 273504
Georges Deschenes
Georges Deschenes
Login now to access Regular content available to all registered users.

You may also access ISN content "anytime, anywhere" with the FREE ISN Academy App for iOS and Android.
Discussion Forum (0)
Rate & Comment (0)
A preview of this visual abstract is available below, and can be downloaded to the left.
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies